ProCE Banner Activity

Improving Patient Outcomes and Providing Cost-Effective Care in EGFR-Mutated NSCLC

Slideset Download
In this downloadable slideset, Philip Schwieterman, PharmD, MHA, reviews pharmacy perspectives in the delivery of care to patients with EGFR-mutated NSCLC.

Released: March 02, 2018

Expiration: March 01, 2019

No longer available for credit.

Share

Faculty

Philip Schwieterman

Philip Schwieterman, PharmD, MHA

Director of Oncology and Pediatric Pharmacy
Markey Cancer Center
UK Health Care
Lexington, Kentucky

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Philip Schwieterman, PharmD, MHA

Director of Oncology and Pediatric Pharmacy
Markey Cancer Center
UK Health Care
Lexington, Kentucky